Cargando…

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa

Extensively drug-resistant tuberculosis (XDR-TB), defined as resistance to at least isoniazid (INH), rifampicin (RIF), a fluoroquinolone (FQ) and a second-line injectable drug (SLID), is difficult to treat and poses a major threat to TB control. The transmission dynamics and distribution of XDR Myco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oostvogels, Selien, Ley, Serej D., Heupink, Tim H., Dippenaar, Anzaan, Streicher, Elizabeth M., De Vos, Elise, Meehan, Conor J., Dheda, Keertan, Warren, Rob, Van Rie, Annelies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453078/ https://www.ncbi.nlm.nih.gov/pubmed/35471145 http://dx.doi.org/10.1099/mgen.0.000815

Ejemplares similares

Spatial Distribution of Drug-Resistant Mycobacterium tuberculosis Infections in Rural Eastern Cape Province of South Africa
por: Faye, Lindiwe M., et al.
Publicado: (2023)

The Detection of Mutations and Genotyping of Drug-Resistant Mycobacterium tuberculosis Strains Isolated from Patients in the Rural Eastern Cape Province
por: Faye, Lindiwe M., et al.
Publicado: (2023)

Nanopore Sequencing for Mycobacterium tuberculosis: a Critical Review of the Literature, New Developments, and Future Opportunities
por: Dippenaar, Anzaan, et al.
Publicado: (2022)

Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data
por: Goossens, Sander N, et al.
Publicado: (2021)

Capacity building for whole genome sequencing of Mycobacterium tuberculosis and bioinformatics in high TB burden countries
por: Rivière, Emmanuel, et al.
Publicado: (2020)

Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa
por: Sy, Karla Therese L., et al.
Publicado: (2022)

A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic
por: Klopper, Marisa, et al.
Publicado: (2020)

TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2022)

Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2023)

The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
por: Tomasicchio, Michele, et al.
Publicado: (2016)

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana
por: Mogashoa, Tuelo, et al.
Publicado: (2019)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study
por: Tu, Pham Hien Trang, et al.
Publicado: (2022)

Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
por: Goig, Galo A, et al.
Publicado: (2023)

High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis
por: Pietersen, Elize, et al.
Publicado: (2015)

GenoType(®) MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2016)

Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes
por: Katende, Bulemba, et al.
Publicado: (2020)

Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea
por: Ley, Serej D, et al.
Publicado: (2014)

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence
por: Anderson, Kim, et al.
Publicado: (2022)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013)

Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013)

Fighting an old disease with next-generation sequencing
por: Dippenaar, Anzaan, et al.
Publicado: (2015)

The diagnostic accuracy of the GenoType® Mtbdrsl assay for the detection of resistance to second-line anti-tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2014)

Clonality and genetic profiles of drug‐resistant Mycobacterium tuberculosis in the Eastern Cape Province, South Africa
por: Bhembe, Nolwazi L., et al.
Publicado: (2019)

Knowledge, Attitudes, and Prevention Practices of Drug Resistant Tuberculosis in the Eastern Cape Province, South Africa
por: Fana, Thanduxolo Elford, et al.
Publicado: (2019)

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa
por: Pietersen, Elize, et al.
Publicado: (2023)

Unexpected Genomic and Phenotypic Diversity of Mycobacterium africanum Lineage 5 Affects Drug Resistance, Protein Secretion, and Immunogenicity
por: Ates, Louis S, et al.
Publicado: (2018)

The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa
por: Ioerger, Thomas R, et al.
Publicado: (2010)

Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2016)

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
por: Deshpande, Devyani, et al.
Publicado: (2017)

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial
por: Van Rie, Annelies, et al.
Publicado: (2022)

Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea
por: Ballif, Marie, et al.
Publicado: (2012)

Comprehensive and accurate genetic variant identification from contaminated and low-coverage Mycobacterium tuberculosis whole genome sequencing data
por: Heupink, Tim H., et al.
Publicado: (2021)

Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
por: Whitfield, Michael G., et al.
Publicado: (2022)

Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
por: Feliciano, Cinara Silva, et al.
Publicado: (2019)

Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance
por: Anderson, K, et al.
Publicado: (2022)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

A Systems Dynamic Model for Drug Abuse and Drug-Related Crime in the Western Cape Province of South Africa
por: Nyabadza, Farai, et al.
Publicado: (2017)

HIV-1 Subtypes B and C Unique Recombinant Forms (URFs) and Transmitted Drug Resistance Identified in the Western Cape Province, South Africa
por: Jacobs, Graeme Brendon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b4km0ul4gi473lkohi2jn2f261